Caricamento...
Adherence, Dosing, and Managing Toxicities With Trifluridine/Tipiracil (TAS-102)
Trifluridine/tipiracil (TAS-102) is a new oral combination therapy approved by the US Food and Drug Administration for the treatment of patients with metastatic colorectal cancer who are refractory to or intolerant of standard chemotherapy. This agent consists of a thymidine-based nucleoside analog...
Salvato in:
| Pubblicato in: | Clin Colorectal Cancer |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5743195/ https://ncbi.nlm.nih.gov/pubmed/28242161 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clcc.2017.01.003 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|